Article
Current status of the prognostic molecular markers in medullary thyroid carcinoma
14 Oct 2020
Abstract excerpt
Medullary thyroid cancer (MTC) is a rare thyroid malignancy, which arises from parafollicular C-cells. It occurs in the hereditary or sporadic form. Hereditary type is a consequence of activation of the RET proto-oncogene by germline mutations, whereas about 80% of sporadic MTC tumors harbor somatic, mainly RET or rarely RAS mutations. According to the current ATA guidelines, a postoperative MTC risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
